Penicillin-resistant Streptococcus pneumoniae in metropolitan New York hospitals

Case control study and molecular typing of resistant isolates

R. B. Roberts, A. Tomasz, A. Corso, J. Hargrave, E. Severina, V. LaBombardi, A. Sampath, S. Mannheimer, G. Pringle, J. Rahal, C. Urban, B. Currie, J. Bartscher, Michael H. Levi, J. Berger, S. Brown, A. Shahidi, R. Leggiadro, M. Hashem, V. Kopetz & 3 others E. Spitzer, K. Van Horn, D. Larone

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

During the 4-month period from January to April, 1998, 476 patients with Streptococcus pneumoniae infections were detected in 12 metropolitan New York hospitals and 112 penicillin-resistant (PRP) isolates (24%) were identified in 11 institutions. A case control study of 100 patients with penicillin-resistant and susceptible pneumococci from four of the widely dispersed hospitals revealed a high incidence of underlying medical illnesses in adult patients (74%), a preponderance of patients with pneumonia (63%), and a majority of patients who had underlying risk factors for pneumonia or invasive disease (51%). In this limited case control study, no difference was noted between cases and controls regarding known risk factors for penicillin-resistant pneumococcal infections. The percentage of single-patient PRP isolates varied among individual hospitals but the mean percentages of PRP from the four participating University Medical Centers and seven community hospitals were similar: 26% and 22% respectively. By E-test, 60% and 26% were high-level penicillin and ceftriaxone resistant, respectively. Pulsed-field gel electrophoresis identified 26 chromosomal macrorestriction patterns among the 103 PRP isolates available for analysis, but almost half (50 isolates or 48%) of these belong to two drug-resistant internationally spread clones, SP23-1 and Sp9/14-3, that were detected in all hospitals and were recovered from invasive and noninvasive sites in both children and adults.

Original languageEnglish (US)
Pages (from-to)137-152
Number of pages16
JournalMicrobial Drug Resistance
Volume7
Issue number2
StatePublished - 2001

Fingerprint

Molecular Typing
Streptococcus pneumoniae
Penicillins
Case-Control Studies
Pneumococcal Infections
Pneumonia
Ceftriaxone
Pulsed Field Gel Electrophoresis
Community Hospital
Clone Cells
Incidence
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology
  • Immunology
  • Microbiology

Cite this

Roberts, R. B., Tomasz, A., Corso, A., Hargrave, J., Severina, E., LaBombardi, V., ... Larone, D. (2001). Penicillin-resistant Streptococcus pneumoniae in metropolitan New York hospitals: Case control study and molecular typing of resistant isolates. Microbial Drug Resistance, 7(2), 137-152.

Penicillin-resistant Streptococcus pneumoniae in metropolitan New York hospitals : Case control study and molecular typing of resistant isolates. / Roberts, R. B.; Tomasz, A.; Corso, A.; Hargrave, J.; Severina, E.; LaBombardi, V.; Sampath, A.; Mannheimer, S.; Pringle, G.; Rahal, J.; Urban, C.; Currie, B.; Bartscher, J.; Levi, Michael H.; Berger, J.; Brown, S.; Shahidi, A.; Leggiadro, R.; Hashem, M.; Kopetz, V.; Spitzer, E.; Van Horn, K.; Larone, D.

In: Microbial Drug Resistance, Vol. 7, No. 2, 2001, p. 137-152.

Research output: Contribution to journalArticle

Roberts, RB, Tomasz, A, Corso, A, Hargrave, J, Severina, E, LaBombardi, V, Sampath, A, Mannheimer, S, Pringle, G, Rahal, J, Urban, C, Currie, B, Bartscher, J, Levi, MH, Berger, J, Brown, S, Shahidi, A, Leggiadro, R, Hashem, M, Kopetz, V, Spitzer, E, Van Horn, K & Larone, D 2001, 'Penicillin-resistant Streptococcus pneumoniae in metropolitan New York hospitals: Case control study and molecular typing of resistant isolates', Microbial Drug Resistance, vol. 7, no. 2, pp. 137-152.
Roberts, R. B. ; Tomasz, A. ; Corso, A. ; Hargrave, J. ; Severina, E. ; LaBombardi, V. ; Sampath, A. ; Mannheimer, S. ; Pringle, G. ; Rahal, J. ; Urban, C. ; Currie, B. ; Bartscher, J. ; Levi, Michael H. ; Berger, J. ; Brown, S. ; Shahidi, A. ; Leggiadro, R. ; Hashem, M. ; Kopetz, V. ; Spitzer, E. ; Van Horn, K. ; Larone, D. / Penicillin-resistant Streptococcus pneumoniae in metropolitan New York hospitals : Case control study and molecular typing of resistant isolates. In: Microbial Drug Resistance. 2001 ; Vol. 7, No. 2. pp. 137-152.
@article{8fb0bf45889c4ad29cd0f52b27e82f8b,
title = "Penicillin-resistant Streptococcus pneumoniae in metropolitan New York hospitals: Case control study and molecular typing of resistant isolates",
abstract = "During the 4-month period from January to April, 1998, 476 patients with Streptococcus pneumoniae infections were detected in 12 metropolitan New York hospitals and 112 penicillin-resistant (PRP) isolates (24{\%}) were identified in 11 institutions. A case control study of 100 patients with penicillin-resistant and susceptible pneumococci from four of the widely dispersed hospitals revealed a high incidence of underlying medical illnesses in adult patients (74{\%}), a preponderance of patients with pneumonia (63{\%}), and a majority of patients who had underlying risk factors for pneumonia or invasive disease (51{\%}). In this limited case control study, no difference was noted between cases and controls regarding known risk factors for penicillin-resistant pneumococcal infections. The percentage of single-patient PRP isolates varied among individual hospitals but the mean percentages of PRP from the four participating University Medical Centers and seven community hospitals were similar: 26{\%} and 22{\%} respectively. By E-test, 60{\%} and 26{\%} were high-level penicillin and ceftriaxone resistant, respectively. Pulsed-field gel electrophoresis identified 26 chromosomal macrorestriction patterns among the 103 PRP isolates available for analysis, but almost half (50 isolates or 48{\%}) of these belong to two drug-resistant internationally spread clones, SP23-1 and Sp9/14-3, that were detected in all hospitals and were recovered from invasive and noninvasive sites in both children and adults.",
author = "Roberts, {R. B.} and A. Tomasz and A. Corso and J. Hargrave and E. Severina and V. LaBombardi and A. Sampath and S. Mannheimer and G. Pringle and J. Rahal and C. Urban and B. Currie and J. Bartscher and Levi, {Michael H.} and J. Berger and S. Brown and A. Shahidi and R. Leggiadro and M. Hashem and V. Kopetz and E. Spitzer and {Van Horn}, K. and D. Larone",
year = "2001",
language = "English (US)",
volume = "7",
pages = "137--152",
journal = "Microbial Drug Resistance",
issn = "1076-6294",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Penicillin-resistant Streptococcus pneumoniae in metropolitan New York hospitals

T2 - Case control study and molecular typing of resistant isolates

AU - Roberts, R. B.

AU - Tomasz, A.

AU - Corso, A.

AU - Hargrave, J.

AU - Severina, E.

AU - LaBombardi, V.

AU - Sampath, A.

AU - Mannheimer, S.

AU - Pringle, G.

AU - Rahal, J.

AU - Urban, C.

AU - Currie, B.

AU - Bartscher, J.

AU - Levi, Michael H.

AU - Berger, J.

AU - Brown, S.

AU - Shahidi, A.

AU - Leggiadro, R.

AU - Hashem, M.

AU - Kopetz, V.

AU - Spitzer, E.

AU - Van Horn, K.

AU - Larone, D.

PY - 2001

Y1 - 2001

N2 - During the 4-month period from January to April, 1998, 476 patients with Streptococcus pneumoniae infections were detected in 12 metropolitan New York hospitals and 112 penicillin-resistant (PRP) isolates (24%) were identified in 11 institutions. A case control study of 100 patients with penicillin-resistant and susceptible pneumococci from four of the widely dispersed hospitals revealed a high incidence of underlying medical illnesses in adult patients (74%), a preponderance of patients with pneumonia (63%), and a majority of patients who had underlying risk factors for pneumonia or invasive disease (51%). In this limited case control study, no difference was noted between cases and controls regarding known risk factors for penicillin-resistant pneumococcal infections. The percentage of single-patient PRP isolates varied among individual hospitals but the mean percentages of PRP from the four participating University Medical Centers and seven community hospitals were similar: 26% and 22% respectively. By E-test, 60% and 26% were high-level penicillin and ceftriaxone resistant, respectively. Pulsed-field gel electrophoresis identified 26 chromosomal macrorestriction patterns among the 103 PRP isolates available for analysis, but almost half (50 isolates or 48%) of these belong to two drug-resistant internationally spread clones, SP23-1 and Sp9/14-3, that were detected in all hospitals and were recovered from invasive and noninvasive sites in both children and adults.

AB - During the 4-month period from January to April, 1998, 476 patients with Streptococcus pneumoniae infections were detected in 12 metropolitan New York hospitals and 112 penicillin-resistant (PRP) isolates (24%) were identified in 11 institutions. A case control study of 100 patients with penicillin-resistant and susceptible pneumococci from four of the widely dispersed hospitals revealed a high incidence of underlying medical illnesses in adult patients (74%), a preponderance of patients with pneumonia (63%), and a majority of patients who had underlying risk factors for pneumonia or invasive disease (51%). In this limited case control study, no difference was noted between cases and controls regarding known risk factors for penicillin-resistant pneumococcal infections. The percentage of single-patient PRP isolates varied among individual hospitals but the mean percentages of PRP from the four participating University Medical Centers and seven community hospitals were similar: 26% and 22% respectively. By E-test, 60% and 26% were high-level penicillin and ceftriaxone resistant, respectively. Pulsed-field gel electrophoresis identified 26 chromosomal macrorestriction patterns among the 103 PRP isolates available for analysis, but almost half (50 isolates or 48%) of these belong to two drug-resistant internationally spread clones, SP23-1 and Sp9/14-3, that were detected in all hospitals and were recovered from invasive and noninvasive sites in both children and adults.

UR - http://www.scopus.com/inward/record.url?scp=0034948838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034948838&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 137

EP - 152

JO - Microbial Drug Resistance

JF - Microbial Drug Resistance

SN - 1076-6294

IS - 2

ER -